Abstract
In the production of immune serum for therapeutic purposes strict attention must be paid to the immunological specificity of the bacteria used for immunization. At present the only serum of which the therapeutic value has been proven is that effective against Type I pneumococcus infection. This serum should have agglutinating power for Type I pneumococcus and should have the power of protecting mice against large amounts of virulent culture. Experiments have shown that for producing the primary immunity most rapidly several series of small doses of dead cultures should be given, the injections being made daily for 6 to 7 days, followed by a week in which no injections are made. To produce the highest type of immunity probably living organisms are required. These should be given in moderate doses daily for 3 days, with an interval of a week between each series of injections. By following accurately the methods described, horses may be made to produce rapidly a high grade of specific serum. The observations so far made indicate the importance of employing small doses of culture frequently repeated in this form of immunization.
Full Text
The Full Text of this article is available as a PDF (1.2 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amoss H. L., Wollstein M. A METHOD FOR THE RAPID PREPARATION OF ANTIMENINGITIS SERUM. J Exp Med. 1916 Mar 1;23(3):403–417. doi: 10.1084/jem.23.3.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blake F. G. METHODS FOR THE DETERMINATION OF PNEUMOCOCCUS TYPES. J Exp Med. 1917 Jul 1;26(1):67–80. doi: 10.1084/jem.26.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bull C. G. IMMUNITY FACTORS IN PNEUMOCOCCUS INFECTION IN THE DOG. J Exp Med. 1916 Jul 1;24(1):7–24. doi: 10.1084/jem.24.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chesney A. M. THE LATENT PERIOD IN THE GROWTH OF BACTERIA. J Exp Med. 1916 Oct 1;24(4):387–418. doi: 10.1084/jem.24.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flexner S., Amoss H. L. THE RAPID PRODUCTION OF ANTIDYSENTERIC SERUM. J Exp Med. 1915 May 1;21(5):515–524. doi: 10.1084/jem.21.5.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gay F. P., Chickering H. T. CONCENTRATION OF THE PROTECTIVE BODIES IN ANTIPNEUMOCOCCUS SERUM BY MEANS OF SPECIFIC PRECIPITATION. J Exp Med. 1915 Apr 1;21(4):389–400. doi: 10.1084/jem.21.4.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hanes F. M. AN IMMUNOLOGICAL STUDY OF PNEUMOCOCCUS MUCOSUS. J Exp Med. 1914 Jan 1;19(1):38–51. doi: 10.1084/jem.19.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wadsworth A. B. STUDIES ON PNEUMOCOCCUS INFECTION IN ANIMALS : SECOND PAPER: ACTION OF IMMUNE SERA ON PNEUMOCOCCUS INFECTION. J Exp Med. 1912 Jul 1;16(1):78–102. doi: 10.1084/jem.16.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]